Invictus Receives $16.5 Million from Warrants and Option Exercises Since Dec 22, 2017 and Increases Funded Capacity in 2018

Invictus Receives $16.5 Million from Warrants and Option Exercises Since Dec 22, 2017 and Increases Funded Capacity in 2018 to 27,200 Kg

Vancouver, BC -- February 5, 2018 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP.’s ("Invictus" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce that it has received an additional $16,536,234 from the exercise of previously issued warrants and options since December 22, 2017, bringing Invictus’ cash balance to approximately $38 million. A total of 9,658,179 warrants and 26,000 options were exercised for proceeds of $16,527,854 and $10,130 respectively. As a result of such exercises, the Company currently has a total of 89,863,485 common shares issued and outstanding. There are 14,686,743 warrants outstanding that would bring cash into the Company of approximately $26 million, and additionally, 8,518,000 stock options outstanding that would bring in approximately $13.2 million.

Invictus’ license holders total annual kilogram capacity after various phases of expansion in 2018 and 2019, complete and in progress, is expected to be approximately 76,400 kg, based on expanding facilities in 2019 to approximately 520,000 square feet. The expected net production capacity to Invictus of approximately 67,000 kg after giving effect to the additional investment as a result of the signed definitive agreement with AB Labs that will bring Invictus’ ownership of AB Labs to 50%. With the recent exercise of warrants and options, Invictus’ funded capacity today is approximately 27,200 kg.

Dan Kriznic, Chairman and CEO commented, “We continue to focus on utilizing our $38 million of cash in treasury to build out additional square footage to meet the expected demand once Canada becomes recreationally legal this year. Our current funded capacity is approximately 27,200 kg, as well as our planned expansion to get our license holders to approximately 76,400 kg in 2019 with a net to Invictus of 67,000 kg bringing us in line with some of our peers that are leading the industry. The Sales license for AB Labs has been a catalyst to getting to this stage and the next catalyst will be our sales license for Acreage Pharms that is expected to occur in this first quarter of 2018.”

About Invictus MD Strategies Corp.

Invictus MD Strategies Corp. is focused on two main verticals within the Canadian cannabis sector, namely the Licensed Producers under the ACMPR, being its 100% investment in Acreage Pharms Ltd., located in West-Central Alberta, and 50% investment in AB Laboratories Inc., located near Hamilton, Ontario which has both its cultivation and sales license under ACMPR. Combined the two licenses and an expected third license under AB Ventures Inc. are expected to have an approximate annual run-rate production capacity of 76,400 kg by 2019. In addition to ACMPR licenses the Company has an 82.5% investment in Future Harvest Development Ltd. a Fertilizer and Nutrients manufacturer based in Kelowna, British Columbia.
For more information, please visit www.invictus-md.com.

On Behalf of the Board,
Dan Kriznic
Chairman & CEO

Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676